A. Kinbara et al. / Tetrahedron xxx (2018) 1e6
5
131.4, 131.3, 129.9 (2C), 128.5 (2C), 128.4, 128.3, 128.2 (2C), 127.8,
127.4 (2C), 60.5 (d, JPC ¼ 6.0 Hz), 53.4, 31.3, 29.4, 28.3, 27.5 (d,
JPC ¼ 8.4 Hz), 22.4, 21.6, 16.3 (d, JPC ¼ 7.2 Hz), 14.0; HRMS (FABþ)
calcd for C30H39NO4PS ([MþH]þ) 540.2337, found 540.2388.
0.129 mmol) with 2g (58.7 mg, 0.150 mmol). Colorless oil; IR (neat)
cmꢁ1: 2980, 1600, 1508, 1454, 1439; 31P NMR (202 MHz, CDCl3)
31.6; 1H NMR (500 MHz, CDCl3)
d
:
d
: 7.78 (1H, d, J ¼ 16.0 Hz), 7.68 (2H,
d, J ¼ 8.6 Hz), 7.43e7.39 (3H, m), 7.31e7.27 (4H, m), 7.14e7.09 (3H,
m), 6.70 (2H, d, J ¼ 6.9 Hz), 6.50 (2H, d, J ¼ 8.6 Hz), 6.41 (2H, d,
J ¼ 7.5 Hz), 4.31 (2H, dd, J ¼ 67.0, 16.6 Hz), 3.95e3.88 (2H, m), 3.71
(3H, s), 2.45 (3H, s), 1.23 (3H, t, J ¼ 6.9 Hz); 13C NMR (125 MHz,
4.7. Ethyl (E)-(2-(ethoxy(phenyl)phosphoryl)oct-1-en-1-
yl)(phenyl)carbamate 7
CDCl3)
d: 156.1 (d, JPC ¼ 2.4 Hz), 144.3, 136.8 (d, JPC ¼ 22.8 Hz), 135.9,
This compound (58.8 mg, 97%) was prepared from 3a (23.2 mg,
0.136 mmol) with 2d (41.5 mg, 0.150 mmol). Colorless oil; IR (neat)
cmꢁ1: 2962, 2927, 2857, 1723, 1620, 1593, 1496, 1463, 1439; 31P
135.4, 131.7, 131.7 (2C, d, JPC ¼ 9.6 Hz), 131.5 (2C, d, JPC ¼ 4.8 Hz),
130.8 (d, JPC ¼ 139.2 Hz), 129.9 (2C), 128.7 (d, JPC ¼ 13.2 Hz), 128.0,
128.0 (2C), 127.9, 127.2 (2C), 127.0, 126.7 (2C), 124.3 (d, JPC ¼ 7.2 Hz),
116.3 (d, JPC ¼ 133.2 Hz), 113.2, 60.7 (d, JPC ¼ 6.0 Hz), 55.1, 49.9, 21.6,
16.3 (d, JPC ¼ 6.0 Hz); HRMS (FABþ) calcd for C31H33NO5PS
([MþH]þ) 562.1817, found 562.1773.
NMR (202 MHz, CDCl3) d d: 7.79
: 35.8; 1H NMR (500 MHz, CDCl3)
(2H, dd, J ¼ 12.0, 6.9 Hz), 7.68 (1H, d, J ¼ 17.2 Hz), 7.52 (1H, t,
J ¼ 6.9 Hz), 7.47e7.44 (2H, m), 7.35 (2H, t, J ¼ 7.5 Hz), 7.29 (1H, t,
J ¼ 6.9 Hz), 7.22 (2H, d, J ¼ 7.5 Hz), 4.23 (2H, q, J ¼ 6.9 Hz), 4.12e4.02
(2H, m), 1.47e1.39 (2H, m), 1.36 (3H, t, J ¼ 6.9 Hz), 1.25 (3H, t,
J ¼ 6.9 Hz), 1.06 (2H, quin, J ¼ 7.5 Hz), 0.95e0.80 (4H, m), 0.76 (3H, t,
4.11. Ethyl (E)-(2-(N-benzyl-4-methylphenylsulfonamido)-1-(4-
chlorophenyl)vinyl)(phenyl)phosphinate 11
J ¼ 7.5 Hz), 0.67 (2H, quin, J ¼ 7.5 Hz); 13C NMR (125 MHz, CDCl3)
d:
154.3, 139.6, 138.5 (d, JPC ¼ 24.0 Hz), 131.8, 131.8, 131.7, 131.7, 131.5
(d, JPC ¼ 135.6 Hz), 128.9 (2C), 128.4, 128.3, 127.6 (2C), 127.4, 63.0,
60.6 (d, JPC ¼ 6.0 Hz), 31.2, 29.1, 28.6, 25.8 (d, JPC ¼ 7.2 Hz), 22.3, 16.4
(d, JPC ¼ 7.2 Hz), 14.3, 13.9; HRMS (FABþ) calcd for C25H35NO4P
([MþH]þ) 444.2304, found 444.2356.
This compound (42.0 mg, 55%) was prepared from 3a (23.2 mg,
0.136 mmol) with 2h (59.4 mg, 0.150 mmol). Colorless oil; IR (neat)
cmꢁ1: 2979, 1602, 1488, 1439; 31P NMR (202 MHz, CDCl3) : 31.1; 1H
d
NMR (500 MHz, CDCl3)
d
: 7.84 (1H, d, J ¼ 16.6 Hz), 7.69 (2H, d,
J ¼ 8.0 Hz), 7.46e7.39 (3H, m), 7.33e7.30 (4H, m), 7.15e7.09 (3H, m),
6.89 (2H, d, J ¼ 8.6 Hz), 6.65 (2H, d, J ¼ 7.5 Hz), 6.39 (2H, d,
J ¼ 6.9 Hz), 4.30 (2H, dd, J ¼ 69.3, 16.6 Hz), 3.94 (2H, dt, J ¼ 7.5,
2.3 Hz), 2.46 (3H, s), 1.25 (3H, t, J ¼ 6.9 Hz); 13C NMR (125 MHz,
4.8. Ethyl (E)-(2-(N-benzyl-4-methylphenylsulfonamido)-1-
phenylvinyl)(phenyl)phosphinate 8
CDCl3)
d
: 144.6, 137.1 (d, JPC ¼ 21.6 Hz), 135.6, 135.0, 133.8 (d,
This compound (70.0 mg, 97%) was prepared from 3a (23.2 mg,
0.136 mmol) with 2e (61.5 mg, 0.170 mmol). Colorless oil; IR (neat)
JPC ¼ 3.6 Hz), 133.0, 131.9 (d, JPC ¼ 2.4 Hz), 131.8, 131.7, 131.7, 130.9,
130.8, 130.4 (d, JPC ¼ 140.4 Hz), 130.0 (2C), 128.6 (d, JPC ¼ 13.2 Hz),
128.2, 128.1 (2C), 127.7, 127.3 (2C), 127.1, 126.3 (2C), 114.9 (d,
JPC ¼ 134.4 Hz), 60.9 (d, JPC ¼ 6.0 Hz), 50.1, 21.6, 16.3 (d, JPC ¼ 7.2 Hz);
HRMS (FABþ) calcd for C30H30ClNO4PS ([MþH]þ) 566.1322, found
566.1272.
cmꢁ1: 1615, 1594, 1492, 1469; 31P NMR (202 MHz, CDCl3) : 31.3; 1H
d
NMR (500 MHz, CDCl3)
d
: 7.84 (1H, d, J ¼ 16.0 Hz), 7.68 (2H, d,
J ¼ 8.0 Hz), 7.43e7.38 (3H, m), 7.32e7.27 (4H, m), 7.15e7.08 (4H, m),
6.96 (2H, t, J ¼ 8.0 Hz), 6.65 (2H, d, J ¼ 7.5 Hz), 6.47 (2H, d,
J ¼ 8.0 Hz), 4.28 (2H, dd, J ¼ 76.8, 16.6 Hz), 3.98e3.87 (2H, m), 2.45
(3H, s), 1.23 (3H, t, J ¼ 7.5 Hz); 13C NMR (125 MHz, CDCl3)
d: 144.4,
4.12. Benzyl (E)-benzyl(2-(isopropoxy(phenyl)phosphoryl)oct-1-
en-1-yl)carbamate 15
136.7 (d, JPC ¼ 21.6 Hz), 135.8, 135.3, 132.5 (d, JPC ¼ 7.2 Hz), 131.7,
131.7, 131.6, 130.7 (d, JPC ¼ 140.4 Hz), 130.4, 130.3, 129.9 (2C), 128.0,
128.0 (2C), 127.9, 127.7, 127.6, 127.6, 127.2 (2C), 127.0, 126.5 (2C),
116.3 (d, JPC ¼ 132.0 Hz), 60.7 (d, JPC ¼ 4.8 Hz), 49.8, 21.6, 16.3 (d,
JPC ¼ 7.2 Hz); HRMS (FABþ) calcd for C30H31NO4PS ([MþH]þ)
532.1711, found 532.1779.
This compound (65.3 mg, 90%) was prepared from 3b (25.0 mg,
0.136 mmol) with 2a (52.4 mg, 0.150 mmol). Colorless oil; IR (neat)
cmꢁ1: 2956, 2927, 1715, 1622, 1496, 1454, 1438; 31P NMR (202 MHz,
CDCl3) d d: 7.67e7.63 (2H, m), 7.47
: 33.5; 1H NMR (500 MHz, CDCl3)
(1H, t, J ¼ 6.9 Hz), 7.38e7.24 (11H, m), 7.17 (2H, d, J ¼ 6.9 Hz), 5.20
(2H, d, J ¼ 4.0 Hz), 4.79 (2H, dd, J ¼ 60.2, 16.0 Hz), 4.52 (1H, m),
2.05e1.92 (2H, m), 1.27e0.94 (14H, m), 0.78 (3H, t, J ¼ 7.5 Hz); 13C
4.9. Methyl (E)-4-(2-(N-benzyl-4-methylphenylsulfonamido)-1-
(ethoxy(phenyl)phosphoryl)vinyl)benzoate 9
NMR (125 MHz, CDCl3)
d: 154.8, 138.0 (d, JPC ¼ 21.6 Hz), 137.1, 135.7,
This compound (62.1 mg, 77%) was prepared from 3a (23.2 mg,
0.136 mmol) with 2f (62.9 mg, 0.150 mmol). Colorless oil; IR (neat)
132.6, 131.7, 131.7, 131.6, 131.5, 128.6 (2C), 128.5 (2C), 128.3 (2C),
128.2, 128.1 (2C), 127.4 (2C), 126.9, 69.8 (d, JPC ¼ 6.0 Hz), 68.3, 50.9,
31.2, 29.3, 28.7, 27.1 (d, JPC ¼ 8.4 Hz), 24.2 (d, JPC ¼ 3.6 Hz), 24.1 (d,
JPC ¼ 4.8 Hz), 22.4, 14.0; HRMS (FABþ) calcd for C32H41NO4P
([MþH]þ) 534.2773, found 534.2810.
cmꢁ1: 2980, 1720, 1605, 1496, 1438; 31P NMR (202 MHz, CDCl3)
d:
30.9; 1H NMR (500 MHz, CDCl3)
d
: 7.89 (1H, d, J ¼ 16.0 Hz), 7.69 (2H,
d, J ¼ 8.6 Hz), 7.61 (2H, d, J ¼ 8.0 Hz), 7.45e7.27 (7H, m), 7.14 (1H, t,
J ¼ 7.5 Hz), 7.08 (2H, t, J ¼ 7.5 Hz), 6.60 (2H, d, J ¼ 7.5 Hz), 6.54 (2H,
dd, J ¼ 8.6, 1.7 Hz), 4.27 (2H, dd, J ¼ 83.1, 16.6 Hz), 3.98e3.90 (2H,
m), 3.88 (3H, s), 2.47 (3H, s), 1.24 (3H, t, J ¼ 6.9 Hz); 13C NMR
4.13. Benzyl (E)-benzyl(2-(tert-butoxy(phenyl)phosphoryl)oct-1-
en-1-yl)carbamate 16
(125 MHz, CDCl3)
d
: 166.6, 144.6, 137.8 (d, JPC ¼ 7.2 Hz), 137.2 (d,
JPC ¼ 20.4 Hz), 135.6, 134.8, 131.9 (d, JPC ¼ 2.4 Hz), 131.7, 131.6, 130.5
(2C, d, JPC ¼ 4.8 Hz), 130.4 (d, JPC ¼ 141.6 Hz), 130.1 (2C), 129.2 (d,
JPC ¼ 2.4 Hz), 128.6 (2C), 128.2, 128.1 (2C), 128.1, 127.2 (2C), 127.2,
126.3 (2C), 115.3 (d, JPC ¼ 130.8 Hz), 60.9 (d, JPC ¼ 6.0 Hz), 52.1, 50.1,
21.6, 16.3 (d, JPC ¼ 7.2 Hz); HRMS (FABþ) calcd for C32H33NO6PS
([MþH]þ) 590.1766, found 590.1741.
This compound (35.9 mg, 48%) was prepared from 3c (27.0 mg,
0.136 mmol) with 2a (52.5 mg, 0.150 mmol). Colorless oil; IR (neat)
cmꢁ1: 2956, 2929, 1715, 1624, 1496, 1455, 1438; 31P NMR (202 MHz,
CDCl3) d d: 7.64e7.60 (2H, m), 7.44
: 29.5; 1H NMR (500 MHz, CDCl3)
(1H, t, J ¼ 6.9 Hz), 7.33e7.21 (11H, m), 7.18 (2H, d, J ¼ 6.9 Hz), 5.19
(2H, d, J ¼ 1.7 Hz), 4.76 (2H, dd, J ¼ 44.7, 16.0 Hz), 2.04e1.91 (2H, m),
1.40 (9H, s), 1.19e0.93 (8H, m), 0.79 (3H, t, J ¼ 7.5 Hz); 13C NMR
4.10. Ethyl (E)-(2-(N-benzyl-4-methylphenylsulfonamido)-1-(4-
(125 MHz, CDCl3) d: 137.1, 135.7, 134.6, 133.5, 131.3, 131.3, 131.3,
methoxyphenyl)vinyl)(phenyl)phosphinate 10
131.2, 128.6 (2C), 128.5 (2C), 128.3, 128.1 (2C), 128.0 (2C), 127.4 (2C),
127.1, 83.2 (d, JPC ¼ 8.4 Hz), 68.2, 51.1, 31.3, 30.7, 30.7 (2C), 29.4, 28.5,
27.2 (d, JPC ¼ 8.4 Hz), 22.4, 14.0; HRMS (FABþ) calcd for C33H43NO4P
This compound (60.1 mg, 83%) was prepared from 3a (22.0 mg,
Please cite this article in press as: A. Kinbara, et al., Nickel-catalyzed regio- and stereoselective hydrophosphinylation of internal ynamides with